KHUSHPREET CHEEMA: Open Payments
NPI 1629489182 · CAMP HILL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,369 in 126 payments from 15 companies in 2025. Trend: 2023 $352 · 2024 $711 · 2025 $2,369
Food & beverage: $2,318Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $459 |
| ABBVIE INC. | 17 | $322 |
| Madrigal Pharmaceuticals | 8 | $266 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $237 |
| Celltrion USA Inc. | 9 | $221 |
| Regeneron Healthcare Solutions, Inc. | 14 | $201 |
| Gilead Sciences, Inc. | 5 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $160 |
| Phathom Pharmaceuticals, Inc. | 7 | $64 |
| Ipsen Biopharmaceuticals, Inc | 4 | $63 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, XIFAXAN, RINVOQ, ENTYVIO, VEGZELMA, Livdelzi.
Industry payments across PA — which companies pay providers there.
